Trial Profile
A phase I, single dose, randomized, double-blind, parallel controlled study to compare the similarity in pharmacokinetics and safety of TAB008 Monoclonal Antibody Injection versus Avastin Injection in healthy Chinese male subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Jun 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 16 Nov 2016 New trial record